Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Hormones – e.g. – prolactin – thymosin – growth factors – etc.
Reexamination Certificate
2003-12-10
2008-12-02
Allen, Marianne P (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Hormones, e.g., prolactin, thymosin, growth factors, etc.
C530S350000, C530S356000, C530S402000, C536S023400, C435S069700
Reexamination Certificate
active
07459541
ABSTRACT:
The present invention relates to compositions and methods for promoting tissue repair and regeneration. The invention provides a fusion polypeptide useful for targeting tissues for regeneration and methods of use therefore.
REFERENCES:
patent: 4980289 (1990-12-01), Temin et al.
patent: 5704910 (1998-01-01), Humes
patent: 6004798 (1999-12-01), Anderson et al.
patent: 6387663 (2002-05-01), Hall et al.
patent: 6955898 (2005-10-01), Hall et al.
patent: 2002/0102709 (2002-08-01), Ishikawa et al.
patent: 2005/0250936 (2005-11-01), Oppermann et al.
patent: WO 96/25179 (1996-08-01), None
patent: WO 96/39430 (1996-12-01), None
patent: WO 98/44938 (1998-10-01), None
Carlini et al. Effect of recombinant human erythropoietin on endothelial cell apoptosis. Kidney International vol. 55, pp. 546-553 (1999).
Dale et al. Compartment switching of WNT-2 expression in human breast tumors. Cancer research 56 4320-4323, Oct. 1, 1996.
Kurada et al. Epidermal growth factor receptor:its role in Drosophila eye differentiation and cell survival. Apoptosis 4:239-243 (1999).
Han et al., “Refolding of a Recombinant Collagen-Targeted TGF-β2 Fusion Protein Expressed inEscherichia coli,” Protein Expression and Purification, vol. 11, p. 169-178 (1997).
Nishi et al., “Collagen-binding growth factors: Production and characterization of functional fusion proteins having a collagen-binding domain,” Proc. Natl. Acad. Sci. USA, vol. 95, p. 7018-7023 (1998).
Gordon et al., “Capture and Expansion of Bone Marrow-Derived Mesenchymal Progenitor Cells with a Transforming Growth Factor-β1-von Willebrand's Factor Fusion Protein for Retrovirus-Mediated Delivery of Coagulation Factor IX,” Human Gene Therapy, vol. 8, p. 1385-1394 (1997).
Hall et al., “Targeting Retroviral Vectors to Vascular Lesions by Genetic Engineering of the MoMLV gp70 Envelope Protein,” Human Gene Therapy, vol. 8, p. 2183-2192 (1997).
Beart Robert W.
Gordon Erlinda M.
Hall Frederick L.
Nimni Marcel
Allen Marianne P
DeBerry Regina M
Fish & Richardson P.C.
University of Southern California
LandOfFree
Matrix-targeted fusion polypeptides for tissue regeneration... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Matrix-targeted fusion polypeptides for tissue regeneration..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Matrix-targeted fusion polypeptides for tissue regeneration... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4024356